Dr Arijit Bishnu is the best haemato- onchologist in Siliguri, with great skills and friendly nature.
CAR T-cell Therapy (Chimeric Antigen Receptor T-cell therapy) is a groundbreaking immunotherapy that harnesses the power of the body’s own immune system to fight hematologic cancers such as leukemia, lymphoma, and myeloma. The therapy involves collecting T-cells (a type of white blood cell) from the patient’s blood, genetically modifying them in a laboratory to express a chimeric antigen receptor (CAR) that recognizes cancer-specific antigens, and then reinfusing the modified T-cells back into the patient. This modification enables the T-cells to specifically target and kill cancer cells with greater precision and efficacy. CAR T-cell therapy has shown remarkable success in treating patients with refractory or relapsed blood cancers, especially in conditions like acute lymphoblastic leukemia (ALL) and diffuse large B-cell lymphoma (DLBCL), where traditional treatments have failed. For example, in some cases of ALL, CAR T-cells have resulted in complete remission for patients who previously had limited options. Despite its potential, CAR T-cell therapy can cause significant side effects, such as cytokine release syndrome (CRS), a systemic inflammatory response, and neurologic toxicities, which need careful monitoring and management by specialized medical teams.
CAR T-cell therapy is administered in a highly controlled setting, typically at specialized cancer treatment centers, and requires rigorous follow-up care. The treatment is tailored to each patient’s unique cancer profile, offering a personalized approach that has the potential to be curative. As research progresses, the scope of CAR T-cell therapy is expanding, with ongoing trials exploring its use in other hematologic malignancies and solid tumors, further solidifying its role as a transformative therapy in hematologic oncology.
Dr. Arijit Bishnu and his team use advanced diagnostics, such as genetic testing and molecular profiling, to determine whether targeted therapy is right for a patient. Treatment is then closely monitored and adjusted based on response and tolerance :
Medical History Review: Understanding your symptoms, lifestyle, and medical history to assess any underlying conditions that may be contributing to the menstrual issues.
Treatment of specific blood cancers - Used in conditions such as chronic myeloid leukemia (CML), chronic lymphocytic leukemia (CLL), certain lymphomas, and myeloproliferative neoplasms.
Molecular targeting - Focuses on proteins, genes, or cellular pathways that drive abnormal blood cell growth or survival.
Genetic testing required -Requires molecular diagnostics to identify the presence of targetable mutations or markers.
Fewer side effects than chemotherapy - Typically spares normal cells, leading to lower risk of hair loss, nausea, or widespread immune suppression.
Key advancement in personalized medicine - Allows hematologists to match treatment to each patient’s unique disease profile for optimal outcomes.
Dr. Arijit Bishnu specializes in the diagnosis and treatment of blood disorders, including anemia, leukemia, lymphoma, and clotting abnormalities. With expertise in advanced haematological care, he is dedicated to providing accurate diagnosis and personalized treatment plans for optimal patient health.
© Dr. Arijit Bishnu. All Rights Reserved.
Designed by Digiex Web